industry

C-CAMP to jointly work on antimicrobial resistance solutions with AMR Global


BENGALURU: Centre for Cellular and Molecular Platforms (C-CAMP) has signed a letter of intent with AMR Global of Netherlands to jointly work on antimicrobial resistance solutions.

C-CAMP, an initiative of the Department of Biotechnology, Ministry of Science and Technology, and the prominent public private partnership organization in the Netherland, have decided to build and nurture innovations that address the global AMR threat.

Activities by the two organisations would pave the way for deeper innovation ties between Dutch and Indian ecosystems to ensure a constant pipeline of antimicrobial resistance innovations, in diagnostics, prevention, drug discovery and vaccines that are globally effective and accessible, said C-CAMP in a release. “Finally, the LoI would be the first step towards facilitating adoption of ‘One Health’ in both geographies.”

Compared to other countries in the European Union, antimicrobial resistance rates are particularly low in the Netherlands, primarily because of early adoption of the ‘One Health’ approach, which aims to combat AMR holistically in the healthcare system, in animals, in food and in the environment through coordinated action.

At the same time, India is sitting on an epicenter of a possible AMR tsunami, said Taslimarif Saiyed, CEO and Director, C-CAMP. “This is largely due to lack of antibiotic stewardship, indiscriminate use of antibiotics in animals and food and untreated effluent, waste and landfill. Also owing to the very nature of the AMR problem, no two countries or even regions in the world face the exact same AMR challenge,” he said.





READ SOURCE

Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.